Otomycosis caused by the cryptic and emerging species Aspergillus sydowii: two case reports

Future Microbiol. 2022 Dec:17:1437-1443. doi: 10.2217/fmb-2022-0137. Epub 2022 Nov 16.

Abstract

Two cases of otomycosis have been reported in patients undergoing tympanomastoidectomy. The first one had chronic otitis media, hypertrophic concha and nasal septum deviation, tympanic perforation and otorrhea. The second had otalgia, pruritus, chronic otitis media and cholesteatoma. Direct examination showed mycelial septate filaments with a branch at an angle close to 45°, later identified as Aspergillus sydowii by sequencing the BenA and CaM genes. Susceptibility testing showed low MIC of amphotericin B, itraconazole, ketoconazole and ciclopirox olamine. In both cases, ketoconazole was instituted for 10 days. Otomycosis is a challenge as it is primarily recurrent in patients undergoing surgery. The clinical implication, the identification of the emerging pathogen and the determination of MIC were necessary for the knowledge of the epidemiological profile and establishment of the treatment.

Keywords: Aspergillus section Nidulantes; emerging species; fungal otitis; minimum inhibitory concentration; mycological diagnosis; treatment.

Plain language summary

Aspergillus are fungi that can cause ear disease. In severe infections, these fungi can be present for long periods inside the ear, and commonly belong to the species Aspergillus section Nigri and Aspergillus flavus. In this work, we present two cases of ear infections by a different species, Aspergillus sydowii. Patients had obstructed nasal cavities, crooked internal separation of the nose and complaints of secretion in the ear. The efficient diagnosis allowed a treatment that resulted in the death of the fungus and the cure of the patient.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Aspergillus / genetics
  • Humans
  • Itraconazole / therapeutic use
  • Ketoconazole / therapeutic use
  • Otomycosis* / diagnosis
  • Otomycosis* / drug therapy

Substances

  • Ketoconazole
  • Itraconazole
  • Antifungal Agents

Supplementary concepts

  • Aspergillus sydowii